FDA Provides Information on Monkeypox Virus to Blood Donation Centers

8/12/22 – Working closely with the CDC and other federal and international agencies to monitor spread of the monkeypox virus, FDA issued a safety communication for blood establishments. FDA notes that there have been no reports of monkeypox transmission through blood transfusion. FDA believe that the robust existing safeguards for blood safety and donor screening is sufficient and does not recommend using laboratory diagnostic tests to screen blood donors for monkeypox. Read the FDA safety communication.